IRIS
GRASSO, Silvana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.696
EU - Europa 11.291
AS - Asia 6.038
SA - Sud America 2.100
Continente sconosciuto - Info sul continente non disponibili 365
AF - Africa 185
OC - Oceania 9
AN - Antartide 1
Totale 38.685
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.511
RU - Federazione Russa 5.380
SG - Singapore 2.365
BR - Brasile 1.841
CN - Cina 1.616
IE - Irlanda 1.461
SE - Svezia 1.244
VN - Vietnam 902
UA - Ucraina 728
IT - Italia 653
DE - Germania 598
HK - Hong Kong 547
FR - Francia 328
FI - Finlandia 303
GB - Regno Unito 267
IN - India 146
AR - Argentina 82
CA - Canada 82
BD - Bangladesh 69
TR - Turchia 69
AT - Austria 51
IQ - Iraq 48
MX - Messico 48
ZA - Sudafrica 47
EC - Ecuador 45
CZ - Repubblica Ceca 42
MA - Marocco 41
NL - Olanda 41
BE - Belgio 40
UZ - Uzbekistan 38
CO - Colombia 35
PL - Polonia 32
VE - Venezuela 30
PK - Pakistan 29
ID - Indonesia 26
ES - Italia 25
IR - Iran 25
CL - Cile 19
JP - Giappone 19
TN - Tunisia 19
PE - Perù 17
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
CI - Costa d'Avorio 15
DZ - Algeria 15
JM - Giamaica 15
PY - Paraguay 15
RO - Romania 13
NP - Nepal 12
UY - Uruguay 12
LV - Lettonia 11
CH - Svizzera 10
IL - Israele 10
KE - Kenya 10
AZ - Azerbaigian 9
EG - Egitto 9
GE - Georgia 9
MY - Malesia 9
EU - Europa 8
SN - Senegal 8
AL - Albania 7
AU - Australia 7
KG - Kirghizistan 7
LT - Lituania 7
BY - Bielorussia 6
CR - Costa Rica 6
DK - Danimarca 6
HN - Honduras 6
JO - Giordania 6
KZ - Kazakistan 6
PA - Panama 6
TT - Trinidad e Tobago 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
DO - Repubblica Dominicana 5
KR - Corea 5
AO - Angola 4
ET - Etiopia 4
GR - Grecia 4
KW - Kuwait 4
LB - Libano 4
PH - Filippine 4
PT - Portogallo 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
EE - Estonia 3
GT - Guatemala 3
LU - Lussemburgo 3
MD - Moldavia 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
BG - Bulgaria 2
GA - Gabon 2
HU - Ungheria 2
LY - Libia 2
ML - Mali 2
NG - Nigeria 2
SY - Repubblica araba siriana 2
Totale 38.301
Salva come PNG Salva come JPEG
Città #
Dallas 9.890
Moscow 1.695
Dublin 1.459
Jacksonville 1.383
Singapore 1.230
Chandler 949
Ashburn 910
Nyköping 812
Dong Ket 629
Beijing 546
Hong Kong 544
Council Bluffs 380
San Jose 328
Princeton 265
The Dalles 256
Cambridge 254
Medford 232
Lauterbourg 219
Dearborn 216
Los Angeles 195
Des Moines 189
Boardman 152
Ann Arbor 143
Messina 140
São Paulo 122
Buffalo 113
Milan 99
Ho Chi Minh City 98
Tianjin 95
Munich 89
New York 82
San Mateo 75
Lancaster 69
Jinan 68
Hanoi 61
Guangzhou 60
Wilmington 58
Redondo Beach 57
Rio de Janeiro 55
Woodbridge 54
Belo Horizonte 50
Vienna 48
Shenyang 45
Houston 39
Santa Clara 38
Brooklyn 36
Brussels 36
Nanjing 36
Orem 36
Tashkent 36
Brno 35
Porto Alegre 34
Frankfurt am Main 32
Shenzhen 32
Augusta 30
Columbus 30
Chicago 29
Amsterdam 28
Warsaw 28
Haikou 27
Johannesburg 27
Hyderabad 26
Pune 26
Zhengzhou 26
Montreal 25
Helsinki 24
Stockholm 24
Brasília 23
Campinas 23
Seattle 23
Chennai 22
Curitiba 21
Fuzhou 21
Rome 21
Taizhou 21
Turku 21
Hebei 19
London 19
Mumbai 19
Ningbo 19
Salvador 19
Shanghai 19
St Petersburg 19
Ardabil 18
Baghdad 18
Changsha 17
Denver 17
Tokyo 17
Atlanta 16
Boston 16
Istanbul 16
Quito 16
Abidjan 15
Da Nang 15
Lima 15
Nanchang 15
Norwalk 15
Nuremberg 15
Toronto 15
Dhaka 14
Totale 25.753
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.735
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.715
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 302
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 295
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 279
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 275
1-(2-Fluorophenyl)- and 1-(3-fluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole 265
1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents 261
1-Adamantanamine derivatives as potential anti-HIV agents 254
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 253
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 241
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 207
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 201
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni 3a-sostituiti 199
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 194
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 193
Cap. 21 - Antitrombotici 192
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 191
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 189
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni isomeri ottenuti da 4-cloro-1,2-fenilendiamina ed acidi 3-acilpropionici 188
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 187
3,5-Dihydro-5-methyl-7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel noncompetitive AMPA receptor antagonists 184
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 179
4,4-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 175
2,3-Benzodiazepines as potential AMPA receptors antagonists 173
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 169
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 169
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 169
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 166
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 164
A simple and efficient synthesis of GYKI 52466 and GYKI 52895 163
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 163
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 161
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 161
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 159
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 159
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 158
Derivati adamantanici a potenziale attività antivirale. 157
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 156
6,7-Methylenedioxyphtalazin-1(2H)-ones as novel and potent anticonvulsant agents 156
Development of novel amides as non covalent inhibitors of immunoproteasome 155
6,7-Methylenedioxyquinazolin-4-ones as Anticonvulsant Agents 152
Annelated 1,5-benzothiazepines 152
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 151
4,5-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 150
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 149
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 149
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 148
Falcipain-2 inhibitors 148
Evaluation of curcumin irreversibility 148
6,7-Methylenedioxyphthalazin-1(2H)-ones as novel and potent anticonvulsant agents 147
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 146
6,7-Metilendiossiftalazin-1(2H)-oni: una nuova classe di potenti agenti anticonvulsivanti. 145
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 145
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 145
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 144
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 143
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 143
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 141
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 140
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 139
7-Chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole and 1-(2,6-difluorophenyl)-6-methyl-1H,3H- thiazolo[3,4-a]benzimidazole 138
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 136
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 135
Cross-metathesis reactions applications to the synthesis of peptidomimetics as potent falcipain-2 inhibitors 134
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 132
2,3-Benzodiazepine-based noncompetitive AMPAR antagonists: design, synthesis, binding affinity and mechanism of inhibition of the GluR2Qflip homomeric receptor channel 132
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 131
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 127
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 127
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 127
Vincamina: sintesi e caratteristiche spettroscopiche 126
Novel potent AMPA/kainate receptor antagonists: Synthesis and anticonvulsant activity of a series of 2-[(4- alkylsemicarbazono)-(4-aminophenyl)methyl]-4,5- methylenedioxyphenylacetic acid alkyl esters 125
Development of peptidomimetic boronates as proteasome inhibitors 125
Development of peptidomimetic boronates as proteasome inhibitors 125
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 125
STRATEGIES FOR SYNTHESIS OF CONFORMATIONALLY CONSTRAINED GLUTAMATE ANALOGUES 124
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 124
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 123
Glutamate Binding-Site Ligands of NMDA Receptors 122
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 122
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 122
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 122
A simple, one-pot synthesis of novel 1H,3H-thiazolo[3,4-A]benzimidazoles 121
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 118
The reaction between 3-acylpropionic acids and the o-phenylenediamine: n.m.r and X-ray analysis of 3a-phenyl-2,3,3a,4-tetrahydropyrrolo[1,2-a]benzimidazol-1-one. 117
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 117
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 117
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 116
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 115
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 115
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 115
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 115
Composti a presumibile attività antitumorale. IV - Sintesi ed attività antileucemica di N,N'-di-[2-(1,3,4-tiadiazolil)]metilendiamine 1-sostituite 114
Synthesis and anticonvulsant activity of novel and potent 6,7- methylenedioxyphthalazin-1(2H)-ones 114
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 114
Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino,3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent 114
Novel peptidomimetics as antiplasmodial falcipain-2 inhibitors 114
C-13 NMR-study of tetrahydrothiazolo-[2,3-D][1,4]benzodiazepin-3(2H)-ones 114
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 114
Totale 24.805
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.182
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.633 0 350 30 70 86 2 103 61 36 61 295 539
2022/20234.222 367 326 182 300 328 467 84 224 1.779 16 98 51
2023/2024847 91 127 69 198 93 92 16 31 4 46 14 66
2024/20254.394 95 44 105 361 205 48 18 1.059 1.223 200 317 719
2025/202620.803 419 3.321 7.312 1.057 853 2.994 1.443 1.414 1.310 367 177 136
2026/2027657 196 461 0 0 0 0 0 0 0 0 0 0
Totale 38.685